General Information of the Compound
Compound ID
CP0309449
Compound Name
bis(5-hydroxy-1-benzofuran-2-yl)methanone
    Show/Hide
Synonyms
Bis(5-hydroxybenzo[b]furan-2-yl)methanone
CHEMBL225826
bis(5-hydroxybenzo[b]furan-2-yl)methanone
    Show/Hide
Structure
Formula
C17H10O5
Molecular Weight
294.262
Canonical SMILES
Oc1ccc2oc(cc2c1)C(=O)c1cc2cc(O)ccc2o1
    Show/Hide
InChI
InChI=1S/C17H10O5/c18-11-1-3-13-9(5-11)7-15(21-13)17(20)16-8-10-6-12(19)2-4-14(10)22-16/h1-8,18-19H
    Show/Hide
InChIKey
TYHFGEDRLCAJMH-UHFFFAOYSA-N
Physicochemical Property
logP
3.8212
Rotatable Bonds
2
Heavy Atom Count
22
Polar Areas
83.81
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 13454380
ChEMBL ID
CHEMBL225826
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01204, Receptor-type tyrosine-protein kinase FLT3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000075 EoL-1 Homo sapiens (Human)  1
1
IC50 = 3600 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Bis(5-hydroxybenzo[b]furan-2-yl)methanone )
Drug Name Bis(5-hydroxybenzo[b]furan-2-yl)methanone
Target(s)
Platelet-derived growth factor receptor beta (PDGFRB)
Inhibitor
Fms-like tyrosine kinase 3 (FLT-3)
Inhibitor